Myositis and myocarditis with tremelimumab and durvalumab combination therapy for hepatocellular carcinoma

Med Clin (Barc). 2023 Dec 2:S0025-7753(23)00673-5. doi: 10.1016/j.medcli.2023.11.003. Online ahead of print.NO ABSTRACTPMID:38044186 | DOI:10.1016/j.medcli.2023.11.003

Source: Medicina Clinica - December 3, 2023 Category: General Medicine Authors: Thais Lizondo L ópez Iria Carro M éndez Esther Carcelero San Mart ín Source Type: research